Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

FDA approves durvalumab with chemotherapy for mismatch repair deficient primary advanced or recurrent endometrial cancer

FDA approves durvalumab with chemotherapy for mismatch repair deficient primary advanced or recurrent endometrial...

FDA approves blinatumomab as consolidation for CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukaemia

FDA approves blinatumomab as consolidation for CD19-positive Philadelphia chromosome-negative B-cell precursor...

FDA grants accelerated approval to repotrectinib for adult and paediatric patients with NTRK gene fusion-positive solid tumours

FDA grants accelerated approval to repotrectinib for adult and paediatric patients with NTRK gene fusion-positive...

$Trametinib shows promise for children with relapsed or refractory JMML$

Trametinib shows promise for children with relapsed or refractory JMML

Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action

Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action

FDA approves selpercatinib for RET fusion-positive thyroid cancer

FDA approves selpercatinib for RET fusion-positive thyroid cancer

Glowing dye helps surgeons eradicate prostate cancer

Glowing dye helps surgeons eradicate prostate cancer

Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed

Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed

Study finds that a common virus can trigger quicker growth of nasopharyngeal cancer

Study finds that a common virus can trigger quicker growth of nasopharyngeal cancer

ASCO 2024: Trastuzumab deruxtecan significantly improves progression-free survival In breast cancer patients previously treated with endocrine therapy

ASCO 2024: Trastuzumab deruxtecan significantly improves progression-free survival In breast cancer patients...

More from ecancer